Sort
39,280 grants matching “leukemia”
Targeting NAMPT in Acute Myeloid Leukemia
$470,916Rosa Lapalombella · Ohio State University · R01 · FY2021 · CA
Targeting NAMPT in Acute Myeloid Leukemia
$470,916Rosa Lapalombella · Ohio State University · R01 · FY2018 · CA
In Vivo Detection And Mechanisms of Regulatory B cell Function in Transplantation
$470,871David M Rothstein · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$470,806Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2019 · CA
MLL FUSION GENES IN MYELOID AND LYMPHOID LEUKEMIAS
$470,757Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Project 1: Ionic Modulation of Chromatin in Cancer
$470,655Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2017 · CA
Chemical Tools for Studying Fucosylated Glycans
$470,643Peng Wu · Scripps Research Institute, The · R01 · FY2016 · GM
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
$470,514Smita Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
$470,471Ross L Levine · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · CA
Diet change among prostate cancer patients under expectant management
$470,450James Marshall · Roswell Park Cancer Institute Corp · R01 · FY2014 · CA
Discovery and Optimization of AML Prognostic Biomarkers
$470,412Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
ROS-targeted therapy for pancreatic cancer
$470,257Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$470,246Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$470,246Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · CA
Genetic Analysis of the Zebrafish Somitogenesis Oscillator
$470,235Scott A Holley · Yale University · R01 · FY2010 · HD
Sequencing and Integrated Analysis of AML Genomes
$470,206Richard K. Wilson · Washington University · P01 · FY2018 · CA
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
$470,120Fatih M Uckun · Children'S Hospital Of Los Angeles · U01 · FY2011 · CA
ONCOGENESIS AND MYELOID TRANSCRIPTION FACTORS IN AML
$470,097Daniel G Tenen · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Preclinical development and clinical monitoring of adoptive immune therapy
$470,080Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
New Gene Regulatory Proteins Regulating Erythroid Development
$470,032Harvey F Lodish · Boston Children'S Hospital · P01 · FY2015 · HL
Transporters and hematopoietic toxicity
$470,030John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2019 · CA
Oncogenic Kit receptor signaling in vivo
$470,003Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2012 · HL
EPIDEMIOLOGY OF T-CELL LEUKEMIA/LYMPHOMA
$470,000University Of The West Indies · N01 · FY2000 · CP
Acute Lymphoblastic Leukemia
$469,989Mary V. Relling · University Of Chicago · U01 · FY2008 · GM
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
$469,946Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA